B
DCPH

Braidwell’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Braidwell’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-609,643
Closed -$9.59M – 85
2024
Q1 		$9.59M Sell
609,643
-559,847
-48% -$8.62M 0.31% 62
2023
Q4 		$18.9M Sell
1,169,490
-2,166,731
-65% -$27.6M 0.69% 43
2023
Q3 		$42.4M Sell
3,336,221
-310,198
-9% -$4.28M 1.34% 27
2023
Q2 		$51.3M Buy
3,646,419
+405,068
+12% +$5.8M 1.68% 15
2023
Q1 		$50.1M Sell
3,241,351
-30,162
-0.9% -$504K 1.65% 21
2022
Q4 		$53.6M Buy
+3,271,513
New +$53.2M 1.8% 16

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Braidwell's DCPH Position: Q2 2024 in Review

Braidwell sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 609,643 shares — an estimated $9.59M sold.

Braidwell first reported a position in DCPH in Q4 2022 and held it in 6 quarters. The position peaked at $53.6M in Q4 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Braidwell reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Braidwell sold 609,643 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $9.59M.
  • Braidwell first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Braidwell's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $53.6M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Braidwell's 13F filing for Q2 2024, filed 14 Aug 2024.